Microneedle Drug Delivery Systems Market : Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2022 to 2030
Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. Sales in the global microneedle drug delivery systems market are slated to increase at a healthy 6.6% CAGR over the forecast period, topping US$ 1.2 Bn by 2030, up from US$ 722.2 Mn in 2022. The market is witnessing surging demand in the field of pharmacy and cosmetics.
The rising incidence of diseases such as cancer, diabetes, migraine, and
others and the need to accurately administer medications are driving the
market. Additionally, the demand for minimally invasive and painless treatment
methods is expected to bode well for the market.
The report uncovers hidden growth opportunities. It also highlights
potential threats to the market players. Some of the key takeaways from the
report are highlighted below.
To remain ‘ahead’ of your competitors, request for a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-2750
Key Takeaways from the Report
·
Solid microneedles are expected to lead the market during forecast
period of 2020-2030 among product type
·
Hospitals are the leading end users of microneedle drug delivery
systems, with specialty clinics gaining popularity.
·
Specialty clinics are expected to grow at an accelerated rate as one of
the key end users of microneedle drug delivery systems
·
North America is the largest market for microneedle drug delivery
systems. Along with Europe, it is expected to cover more than 70% of the market
by end of 2030.
·
East Asia is expected to be the fastest growing regional market during
the next decade.
Covid 19 Restricting Pace of Growth
The onset of pandemic has disturbed the entire business ecosystem. With
productions coming to a halt and supply chains disrupted due to lack of
transport, manufacturers of microneedle drug delivery systems are impacted in a
big way.
Also, because of several restrictions by governments like social
distancing, doctors and practitioners are choosing to avoid any surgical
treatments which are not absolutely and immediately necessary.
Furthermore, cosmetic field which is another major user of microneedle
drug delivery systems is also impacted as almost all treatments under their
umbrella are considered to be not urgent.
Who is winning?
The key market players in microneedle drug delivery systems market
include the 3M Company, Becton, Dickinson and Company, Zosano Pharma
Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc.,
Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc.,
Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and
AdminMed Nano BioSciences LLC
Full Report @ https://www.futuremarketinsights.com/reports/microneedle-drug-delivery-systems-market
Comments
Post a Comment